ArticleInflammopharmacology2022

Repurposing monoamine oxidase inhibitors (MAOI) for the treatment of rheumatoid arthritis possibly through modulating reactive oxidative stress mediated inflammatory cytokines.

Debjeet Sur et al.PubMed ↗Publisher ↗

No numbers read from the abstract.